These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 37720349)

  • 1. Nanomedicine strategies to counteract cancer stemness and chemoresistance.
    Liu H; Liu M; Zhao Y; Mo R
    Explor Target Antitumor Ther; 2023; 4(4):630-656. PubMed ID: 37720349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities.
    De Angelis ML; Francescangeli F; Zeuner A
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31619007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can nanomedicines kill cancer stem cells?
    Zhao Y; Alakhova DY; Kabanov AV
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
    Xie FY; Xu WH; Yin C; Zhang GQ; Zhong YQ; Gao J
    World J Gastrointest Oncol; 2016 Oct; 8(10):735-744. PubMed ID: 27795813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.
    Singh VK; Saini A; Chandra R
    Front Mol Biosci; 2017; 4():52. PubMed ID: 28785557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming Cancer Stem-like Cells with Nanoforskolin Enhances the Efficacy of Paclitaxel in Targeting Breast Cancer.
    Singh D; Singh P; Pradhan A; Srivastava R; Sahoo SK
    ACS Appl Bio Mater; 2021 Apr; 4(4):3670-3685. PubMed ID: 35014452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell theory: therapeutic implications for nanomedicine.
    Wang K; Wu X; Wang J; Huang J
    Int J Nanomedicine; 2013; 8():899-908. PubMed ID: 23467584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine-mediated drug targeting of cancer stem cells.
    Singh D; Minz AP; Sahoo SK
    Drug Discov Today; 2017 Jun; 22(6):952-959. PubMed ID: 28435061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer.
    Zhao J; Li J; Schlößer HA; Popp F; Popp MC; Alakus H; Jauch KW; Bruns CJ; Zhao Y
    Stem Cells Int; 2017; 2017():6012810. PubMed ID: 28845161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor.
    Shen S; Li T; Fan J; Shao Q; Dong H; Xu X; Mo R
    Acta Pharm Sin B; 2023 Mar; 13(3):1262-1273. PubMed ID: 36970217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron metabolism: backfire of cancer cell stemness and therapeutic modalities.
    Yu R; Hang Y; Tsai HI; Wang D; Zhu H
    Cancer Cell Int; 2024 May; 24(1):157. PubMed ID: 38704599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells.
    Rahman MA; Saha SK; Rahman MS; Uddin MJ; Uddin MS; Pang MG; Rhim H; Cho SG
    Front Cell Dev Biol; 2020; 8():283. PubMed ID: 32391363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nanomedicines to overcome cancer multidrug resistance.
    Su Z; Dong S; Zhao SC; Liu K; Tan Y; Jiang X; Assaraf YG; Qin B; Chen ZS; Zou C
    Drug Resist Updat; 2021 Sep; 58():100777. PubMed ID: 34481195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cells and drug resistance: the potential of nanomedicine.
    Vinogradov S; Wei X
    Nanomedicine (Lond); 2012 Apr; 7(4):597-615. PubMed ID: 22471722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotency inducing Yamanaka factors: role in stemness and chemoresistance of liver cancer.
    Fatma H; Siddique HR
    Expert Rev Anticancer Ther; 2021 Aug; 21(8):853-864. PubMed ID: 33832395
    [No Abstract]   [Full Text] [Related]  

  • 19. Advances of nanotechnology applied to cancer stem cells.
    Yue M; Guo T; Nie DY; Zhu YX; Lin M
    World J Stem Cells; 2023 Jun; 15(6):514-529. PubMed ID: 37424953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance.
    Tekchandani P; Kurmi BD; Paliwal SR
    Mini Rev Med Chem; 2017; 17(18):1793-1810. PubMed ID: 26891930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.